Selecta Biosciences Raises $15 Million

Selecta Biosciences Inc., a Watertown, Mass.-based biopharma company focused on the development of immunomodulatory nanoparticles, has raised $15 million in Series C funding. OrbiMed Advisors led the round, and was joined by return backers Polaris Venture Partners, Flagship Ventures, NanoDimension and Leukon Investments. The company previously raised $17.4 million.

North AmericaUSBriefs